Tokyo Tape
Sign in
← Muromachi Chemicals

Annual report

4885.TEDINET S100WL9D
Period2024-06-01 → 2025-05-31
Filed2025-08-26
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 93
MetricValuePeriodScopeSource row
Revenue¥6.7bn2024-06-01 → 2025-05-31StandaloneNet sales
Revenue¥6.4bn2023-06-01 → 2024-05-31StandaloneNet sales
Revenue¥6.3bn2022-06-01 → 2023-05-31vStandaloneNet sales (5-year summary)
Revenue¥5.7bn2021-06-01 → 2022-05-31vStandaloneNet sales (5-year summary)
Revenue¥4.9bn2020-06-01 → 2021-05-31dStandaloneNet sales (5-year summary)
Operating income¥432m2024-06-01 → 2025-05-31StandaloneOperating income
Operating income¥422m2023-06-01 → 2024-05-31StandaloneOperating income
Ordinary income¥430m2024-06-01 → 2025-05-31StandaloneOrdinary income
Ordinary income¥428m2023-06-01 → 2024-05-31StandaloneOrdinary income
Ordinary income¥351m2022-06-01 → 2023-05-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥423m2021-06-01 → 2022-05-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥339m2020-06-01 → 2021-05-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥350m2024-06-01 → 2025-05-31StandaloneIncome before income taxes
Profit before tax¥469m2023-06-01 → 2024-05-31StandaloneIncome before income taxes
Net income¥241m2024-06-01 → 2025-05-31StandaloneProfit loss
Net income¥330m2023-06-01 → 2024-05-31StandaloneProfit loss
Net income¥256m2022-06-01 → 2023-05-31vStandaloneNet income loss (5-year summary)
Net income¥456m2021-06-01 → 2022-05-31vStandaloneNet income loss (5-year summary)
Net income¥181m2020-06-01 → 2021-05-31dStandaloneNet income loss (5-year summary)
Total assets¥5.3bnat 2025-05-31StandaloneAssets
Total assets¥5.1bnat 2024-05-31StandaloneAssets
Total assets¥4.9bnat 2023-05-31vStandaloneTotal assets (5-year summary)
Total assets¥4.8bnat 2022-05-31vStandaloneTotal assets (5-year summary)
Total assets¥4.6bnat 2021-05-31dStandaloneTotal assets (5-year summary)
Total liabilities¥2.8bnat 2025-05-31StandaloneLiabilities
Total liabilities¥2.8bnat 2024-05-31StandaloneLiabilities
Net assets / equity¥2.5bnat 2025-05-31StandaloneNet assets
Net assets / equity¥2.3bnat 2024-05-31StandaloneNet assets
Net assets / equity¥1.9bnat 2023-05-31vStandaloneNet assets
Net assets / equity¥1.7bnat 2022-05-31vStandaloneNet assets (5-year summary)
Net assets / equity¥1.3bnat 2021-05-31dStandaloneNet assets (5-year summary)
Cash and deposits¥1.1bnat 2025-05-31StandaloneCash and deposits
Cash and deposits¥1.1bnat 2024-05-31StandaloneCash and deposits
Cash & equivalents¥1.0bnat 2025-05-31StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2024-05-31StandaloneCash and cash equivalents
Cash & equivalents¥853mat 2023-05-31vStandaloneCash and cash equivalents
Cash & equivalents¥865mat 2022-05-31vStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥1.0bnat 2021-05-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥216m2024-06-01 → 2025-05-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥638m2023-06-01 → 2024-05-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥317m2022-06-01 → 2023-05-31vStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥525m2021-06-01 → 2022-05-31vStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥488m2020-06-01 → 2021-05-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥371m2024-06-01 → 2025-05-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥232m2023-06-01 → 2024-05-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥162m2022-06-01 → 2023-05-31vStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥176m2021-06-01 → 2022-05-31vStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥58m2020-06-01 → 2021-05-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥123m2024-06-01 → 2025-05-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥210m2023-06-01 → 2024-05-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥172m2022-06-01 → 2023-05-31vStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥484m2021-06-01 → 2022-05-31vStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥311m2020-06-01 → 2021-05-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥60.422024-06-01 → 2025-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥83.422023-06-01 → 2024-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥67.942022-06-01 → 2023-05-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥123.792021-06-01 → 2022-05-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥65.242020-06-01 → 2021-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥59.492024-06-01 → 2025-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥81.862023-06-01 → 2024-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥64.122022-06-01 → 2023-05-31vStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥112.562021-06-01 → 2022-05-31vStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥56.972020-06-01 → 2021-05-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥252024-06-01 → 2025-05-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥222023-06-01 → 2024-05-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥192022-06-01 → 2023-05-31vStandaloneDividend paid per share (5-year summary)
Dividend per share¥192021-06-01 → 2022-05-31vStandaloneDividend paid per share (5-year summary)
Dividend per share¥152020-06-01 → 2021-05-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥612.4at 2025-05-31StandaloneNet assets per share (5-year summary)
Net assets per share¥571.26at 2024-05-31StandaloneNet assets per share (5-year summary)
Net assets per share¥487.25at 2023-05-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥450.37at 2022-05-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥363.93at 2021-05-31dStandaloneNet assets per share (5-year summary)
Equity ratio46.6%at 2025-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio44.9%at 2024-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio38.7%at 2023-05-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio35.0%at 2022-05-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio28.9%at 2021-05-31dStandaloneEquity to asset ratio (5-year summary)
ROE10.2%2024-06-01 → 2025-05-31StandaloneRate of return on equity (5-year summary)
ROE15.8%2023-06-01 → 2024-05-31StandaloneRate of return on equity (5-year summary)
ROE14.3%2022-06-01 → 2023-05-31vStandaloneRate of return on equity (5-year summary)
ROE30.3%2021-06-01 → 2022-05-31vStandaloneRate of return on equity (5-year summary)
ROE22.8%2020-06-01 → 2021-05-31dStandaloneRate of return on equity (5-year summary)
Shares issued4,095,500at 2025-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2024-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2023-05-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2022-05-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2021-05-31dStandaloneTotal number of issued shares (5-year summary)
Employees203at 2025-05-31StandaloneNumber of employees
Employees205at 2024-05-31StandaloneNumber of employees
Employees205at 2023-05-31vStandaloneNumber of employees
Employees197at 2022-05-31vStandaloneNumber of employees
Employees195at 2021-05-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 53
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment assetsat 2025-05-31¥1.7bn
Chemical Products Businessreportable segmentcapex2024-06-01 → 2025-05-31¥78m
Chemical Products Businessreportable segmentdepreciation2024-06-01 → 2025-05-31¥61m
Chemical Products Businessreportable segmentemployeesat 2025-05-3152 pure
Chemical Products Businessreportable segmentrevenue2024-06-01 → 2025-05-31¥2.4bn
Chemical Products Businessreportable segmentrevenue external2024-06-01 → 2025-05-31¥2.4bn
Chemical Products Businessreportable segmentsegment assetsat 2025-05-31¥1.1bn
Chemical Products Businessreportable segmentsegment profit2024-06-01 → 2025-05-31¥57m
Healthy Food Businessreportable segmentcapex2024-06-01 → 2025-05-31¥33m
Healthy Food Businessreportable segmentdepreciation2024-06-01 → 2025-05-31¥28m
Healthy Food Businessreportable segmentemployeesat 2025-05-3121 pure
Healthy Food Businessreportable segmentrevenue2024-06-01 → 2025-05-31¥1.0bn
Healthy Food Businessreportable segmentrevenue external2024-06-01 → 2025-05-31¥1.0bn
Healthy Food Businessreportable segmentsegment assetsat 2025-05-31¥334m
Healthy Food Businessreportable segmentsegment profit2024-06-01 → 2025-05-31−¥99m
Pharmaceutical Businessreportable segmentcapex2024-06-01 → 2025-05-31¥182m
Pharmaceutical Businessreportable segmentdepreciation2024-06-01 → 2025-05-31¥74m
Pharmaceutical Businessreportable segmentemployeesat 2025-05-3155 pure
Pharmaceutical Businessreportable segmentrevenue2024-06-01 → 2025-05-31¥3.2bn
Pharmaceutical Businessreportable segmentrevenue external2024-06-01 → 2025-05-31¥3.2bn
Pharmaceutical Businessreportable segmentsegment assetsat 2025-05-31¥2.1bn
Pharmaceutical Businessreportable segmentsegment profit2024-06-01 → 2025-05-31¥474m
Total Of Reportable Segments And Otherssegment totalcapex2024-06-01 → 2025-05-31¥292m
Total Of Reportable Segments And Otherssegment totaldepreciation2024-06-01 → 2025-05-31¥162m
Total Of Reportable Segments And Otherssegment totalrevenue2024-06-01 → 2025-05-31¥6.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-06-01 → 2025-05-31¥6.7bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2025-05-31¥3.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-06-01 → 2025-05-31¥432m
Reconciling Itemsreconcilingsegment assetsat 2024-05-31¥1.6bn
Chemical Products Businessreportable segmentcapex2023-06-01 → 2024-05-31¥77m
Chemical Products Businessreportable segmentdepreciation2023-06-01 → 2024-05-31¥56m
Chemical Products Businessreportable segmentrevenue2023-06-01 → 2024-05-31¥2.3bn
Chemical Products Businessreportable segmentrevenue external2023-06-01 → 2024-05-31¥2.3bn
Chemical Products Businessreportable segmentsegment assetsat 2024-05-31¥1.1bn
Chemical Products Businessreportable segmentsegment profit2023-06-01 → 2024-05-31−¥16m
Healthy Food Businessreportable segmentcapex2023-06-01 → 2024-05-31¥15m
Healthy Food Businessreportable segmentdepreciation2023-06-01 → 2024-05-31¥27m
Healthy Food Businessreportable segmentrevenue2023-06-01 → 2024-05-31¥834m
Healthy Food Businessreportable segmentrevenue external2023-06-01 → 2024-05-31¥834m
Healthy Food Businessreportable segmentsegment assetsat 2024-05-31¥473m
Healthy Food Businessreportable segmentsegment profit2023-06-01 → 2024-05-31−¥38m
Pharmaceutical Businessreportable segmentcapex2023-06-01 → 2024-05-31¥198m
Pharmaceutical Businessreportable segmentdepreciation2023-06-01 → 2024-05-31¥54m
Pharmaceutical Businessreportable segmentrevenue2023-06-01 → 2024-05-31¥3.3bn
Pharmaceutical Businessreportable segmentrevenue external2023-06-01 → 2024-05-31¥3.3bn
Pharmaceutical Businessreportable segmentsegment assetsat 2024-05-31¥1.9bn
Pharmaceutical Businessreportable segmentsegment profit2023-06-01 → 2024-05-31¥476m
Total Of Reportable Segments And Otherssegment totalcapex2023-06-01 → 2024-05-31¥289m
Total Of Reportable Segments And Otherssegment totaldepreciation2023-06-01 → 2024-05-31¥136m
Total Of Reportable Segments And Otherssegment totalrevenue2023-06-01 → 2024-05-31¥6.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-06-01 → 2024-05-31¥6.4bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2024-05-31¥3.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-06-01 → 2024-05-31¥422m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,236
ItemContextValueUnit
Net salesCurrentYearDuration_NonConsolidatedMember6653028000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000PharmaceuticalBusinessReportableSegmentMember473568000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000HealthyFoodBusinessReportableSegmentMember-98556000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000ChemicalProductsBusinessReportableSegmentMember57176000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember432188000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember432188000JPY
AssetsCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E36350-000PharmaceuticalBusinessReportableSegmentMember2092410000JPY
AssetsCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E36350-000HealthyFoodBusinessReportableSegmentMember333635000JPY
AssetsCurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E36350-000ChemicalProductsBusinessReportableSegmentMember1088658000JPY
AssetsCurrentYearInstant_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember3514705000JPY
AssetsCurrentYearInstant_NonConsolidatedMember_ReconcilingItemsMember1749869000JPY
AssetsCurrentYearInstant_NonConsolidatedMember5264574000JPY
Depreciation segment informationCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000PharmaceuticalBusinessReportableSegmentMember73631000JPY
Depreciation segment informationCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000HealthyFoodBusinessReportableSegmentMember27512000JPY
Depreciation segment informationCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000ChemicalProductsBusinessReportableSegmentMember60604000JPY
Depreciation segment informationCurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember161748000JPY
Depreciation segment informationCurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Depreciation segment informationCurrentYearDuration_NonConsolidatedMember161748000JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000PharmaceuticalBusinessReportableSegmentMember181712000JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000HealthyFoodBusinessReportableSegmentMember32919000JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000ChemicalProductsBusinessReportableSegmentMember77559000JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_NonConsolidatedMember_TotalOfReportableSegmentsAndOthersMember292191000JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Increase in property plant and equipment and intangible assetsCurrentYearDuration_NonConsolidatedMember292191000JPY
Impairment loss elCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000PharmaceuticalBusinessReportableSegmentMember－JPY
Impairment loss elCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000HealthyFoodBusinessReportableSegmentMember79758000JPY
Impairment loss elCurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E36350-000ChemicalProductsBusinessReportableSegmentMember－JPY
Impairment loss elCurrentYearDuration_NonConsolidatedMember_ReportableSegmentsMember79758000JPY
Impairment loss elCurrentYearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Impairment loss elCurrentYearDuration_NonConsolidatedMember79758000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第1項
Place of filing cover pageFilingDateInstant
Original text (Japanese)福岡財務支局長
Filing date cover pageFilingDateInstant2025-08-26
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第79期(自　2024年6月1日　至　2025年5月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)室町ケミカル株式会社
Company name in english cover pageFilingDateInstantMUROMACHI CHEMICALS INC.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　青木　淳一
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)福岡県大牟田市新勝立町一丁目38番5
Telephone number address of registered headquarter cover pageFilingDateInstant0944-41-2131
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役　　井内　聡
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)福岡県大牟田市新勝立町一丁目38番5
Telephone number nearest place of contact cover pageFilingDateInstant0944-41-2131
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役　　井内　聡
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE36350
Fund codeFilingDateInstant－
Security codeFilingDateInstant48850
Filer name in japaneseFilingDateInstant
Original text (Japanese)室町ケミカル株式会社

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2024-05-31pass
balance sheet identitynon_consolidated 2025-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-05-31pass
statement vs summary · net assetsnon_consolidated 2024-05-31pass
statement vs summary · net assetsnon_consolidated 2025-05-31pass
statement vs summary · operating cash flownon_consolidated 2023-06-01/2024-05-31pass
statement vs summary · operating cash flownon_consolidated 2024-06-01/2025-05-31pass
statement vs summary · revenuenon_consolidated 2023-06-01/2024-05-31pass
statement vs summary · revenuenon_consolidated 2024-06-01/2025-05-31pass
statement vs summary · total assetsnon_consolidated 2024-05-31pass
statement vs summary · total assetsnon_consolidated 2025-05-31pass